Cytoplasmic LXR expression is an independent marker of poor prognosis for patients with early stage primary breast cancer
- DOI
- 10.1007/s00432-021-03670-y
- Published
- 2021-06-03
- Container
- Journal of Cancer Research and Clinical Oncology
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s00432-021-03670-y,
title = {Cytoplasmic LXR expression is an independent marker of poor prognosis for patients with early stage primary breast cancer},
author = {Wanting Shao and Christina Kuhn and Doris Mayr and Nina Ditsch and Magdalena Kailuwait and Verena Wolf and Nadia Harbeck and Sven Mahner and Udo Jeschke and Vincent Cavaillès and Sophie Sixou},
year = {2021},
journal = {Journal of Cancer Research and Clinical Oncology},
doi = {10.1007/s00432-021-03670-y},
url = {https://doi.org/10.1007/s00432-021-03670-y}
}RIS
TY - JOUR TI - Cytoplasmic LXR expression is an independent marker of poor prognosis for patients with early stage primary breast cancer AU - Wanting Shao AU - Christina Kuhn AU - Doris Mayr AU - Nina Ditsch AU - Magdalena Kailuwait AU - Verena Wolf AU - Nadia Harbeck AU - Sven Mahner AU - Udo Jeschke AU - Vincent Cavaillès AU - Sophie Sixou PY - 2021 JO - Journal of Cancer Research and Clinical Oncology DO - 10.1007/s00432-021-03670-y UR - https://doi.org/10.1007/s00432-021-03670-y ER -
APA
Shao, W., Kuhn, C., Mayr, D., Ditsch, N., Kailuwait, M., Wolf, V., Harbeck, N., Mahner, S., Jeschke, U., Cavaillès, V., & Sixou, S. (2021). Cytoplasmic LXR expression is an independent marker of poor prognosis for patients with early stage primary breast cancer. Journal of Cancer Research and Clinical Oncology. https://doi.org/10.1007/s00432-021-03670-y
Source records
- crossref · retrieved 2026-09-26T19:43:52.225Z